SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: SAB Biotherapeutics, Inc. MIAMI, March…
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
March 17, 2026 22:46 ET | Source: CytomX Therapeutics Inc. SOUTH SAN…
KuCoin Launches Stock Index Perpetual Contracts, Expanding 24/7 Cross-Asset Access
PROVIDENCIALES, Turks and Caicos Islands, March 13, 2026 /PRNewswire/ -- KuCoin, a…
MEXC and Ondo Finance Expand Tokenized Stock Partnership with 17 New Spot Pairs and Zero-Fee Trading
VICTORIA, Seychelles, March 3, 2026 /PRNewswire/ -- MEXC, the fastest-growing global cryptocurrency…
Elliott Management Statement on London Stock Exchange Group plc
LONDON, Feb. 27, 2026 /PRNewswire/ -- Elliott Investment Management L.P. and Elliott Advisors…
Trading Technologies to Provide Direct Connectivity to the National Stock Exchange of India
MUMBAI, India, Feb. 25, 2026 /PRNewswire/ -- Trading Technologies International, Inc. (TT),…
NYSE Content Update: Stock Market to Open Like Normal Amid Historic NYC Blizzard
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK,…
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
February 12, 2026 21:18 ET | Source: Coherus Oncology, Inc. REDWOOD CITY,…
Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger
January 30, 2026 17:15 ET | Source: Enzon Pharmaceuticals, Inc CRANFORD, N.J.,…
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
January 23, 2026 17:00 ET | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN…
